C. Cupp et al., EVIDENCE FOR STIMULATION OF THE TRANSFORMING GROWTH-FACTOR-BETA-1 PROMOTER BY HIV-1 TAT IN CELLS DERIVED FROM CNS, Oncogene, 8(8), 1993, pp. 2231-2236
Infection by human immunodeficiency virus type 1 (HIV-1), the etiologi
c agent of the acquired immunodeficiency syndrome (AIDS), is often com
plicated with a high incidence of neurologic disorders. It is believed
that HIV-1, in addition to infecting both macroglial and microglial c
ells, may influence the expression of several strategic genes of uninf
ected neighboring or latently infected brain cells. It is suspected th
at the viral-encoded transregulatory protein, Tat, facilitates cross-c
ommunications between these cells. In support of this concept, earlier
studies demonstrated that Tat is released from the infected cells, an
d has the capacity to be taken up by the uninfected cells and exert it
s biological activity on the responsive gene. Recent studies in severa
l laboratories suggest the involvement of Tat in altering the expressi
on of a limited number of cellular regulatory factors which, in turn,
may mediate the altered physiology of the cells. In this communication
, we demonstrate the ability of the HIV-1 Tat protein to increase expr
ession of transforming growth factor beta1 (TGF-beta1), a cytokine wit
h potent immunosuppressive activity, in human astrocytic glial cells.
Implications of the Tat-mediated induction of TGF-beta1 expression and
cytokine involvement in the regulation of immune response and central
nervous system (CNS) pathology are discussed.